retatrutide study results Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial New Retatrutide Phase 3 Trial

Still, there is no universal day when side effects begin or a guarantee that they disappear by month 3

Skin reactions that are mild and settle within a few days are expected

Jonesboro, Arkansas, United States: StatPearls (2024)

It induces lipolysis (fat breakdown) in adipose tissue, increasing the production of free fatty acids and ketone bodies

For patients with diabetes, dehydration poses additional risks by potentially affecting kidney function and blood glucose stability

The availability of oral semaglutide may help to broaden treatment options and facilitate the adoption of earlier treatment with arGLP-1 in the management of DM2